N-(2-Bromophenyl)-2-((5-(4-(tert-butyl)phenyl)-4-(4-methoxyphenyl)-4H-1,2,4-triazol-3-yl)thio)acetamide

Catalog No. :
ACPKIC424
CAS No. :
477313-60-3
Molecular Formula :
C27H27BrN4O2S
Molecular Weight :
551.51

IUPAC Name:N-(2-bromophenyl)-2-((5-(4-(tert-butyl)phenyl)-4-(4-methoxyphenyl)-4H-1,2,4-triazol-3-yl)thio)acetamide

N-(2-Bromophenyl)-2-((5-(4-(tert-butyl)phenyl)-4-(4-methoxyphenyl)-4H-1,2,4-triazol-3-yl)thio)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-Bromophenyl)-2-((5-(4-(tert-butyl)phenyl)-4-(4-methoxyphenyl)-4H-1,2,4-triazol-3-yl)thio)acetamide
IUPAC NameN-(2-bromophenyl)-2-((5-(4-(tert-butyl)phenyl)-4-(4-methoxyphenyl)-4H-1,2,4-triazol-3-yl)thio)acetamide
Molecular FormulaC27H27BrN4O2S
Molecular Weight551.51
SMILESO=C(NC1=CC=CC=C1Br)CSC2=NN=C(C3=CC=C(C(C)(C)C)C=C3)N2C4=CC=C(OC)C=C4
InChI KeyMDCMILXKBIQTGA-UHFFFAOYSA-N
SynonymSALOR-INT L227358-1EA;N-(2-BROMOPHENYL)-2-([5-(4-TERT-BUTYLPHENYL)-4-(4-METHOXYPHENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL)ACETAMIDE;Acetamide, N-(2-bromophenyl)-2-[[5-[4-(1,1-dimethylethyl)phenyl]-4-(4-methoxyphenyl)-4H-1,2,4-triazol-3-yl]thio]-
CAS No.477313-60-3

Synthetic Route by SureRoute

1. ACPKIC424 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCGWL165 route compound structure diagram
    ACCGWL16594718-79-3 In Stock
  4. Then
  5. ACPKIC424 route product structure diagram
    ACPKIC424477313-60-3
Inquiry

2. ACPKIC424 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPKIC424 route product structure diagram
    ACPKIC424477313-60-3
Inquiry

Comments (0)